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Summary.-A randomized trial is reported which evaluates the effect of early diag-
nostic splenectomy on the prognosis of patients with Hodgkin's disease (HD) and
uncertain prognosis. This was started in January 1973 and concluded in April 1979.
Sixty-seven patients were entered in the study and 31 were randomized for splen-
ectomy. All patients except 2 received total nodal irradiation, excluding the splenic
and hepatic areas. After 40 months' observation there was no difference between the
groups in respect of survival and the number of recurrences. However, relapses
occurred earlier in the splenectomized patients. Pneumococcal septicaemia was
recorded in 2 splenectomized patients. It is concluded that prognosis is not improved
by diagnostic splenectomy in HD patients with uncertain prognosis and treated
with total nodal irradiation.
EXPLORATORY LAPAROTOMY comprising
diagnostic splenectomy with liver and
lymphnode biopsy was introduced for the
clinical staging of Hodgkin's disease by
(Glatstein et al. (1969). The rationale ofthis
procedure has been supported by the un-
expected finding of abdominal involve-
ment in a large proportion of patients
resulting in a more extensive treatment
(Aisenberg et al., 1971; Meeker et al., 1972;
H0st et al., 1973; Rozman et al., 1973;
Kaplan et al., 1973; Andersen & Videbaek,
1974; Smithers et al., 1974; B.N.L.I., 1975;
Irving, 1975; Somers et al., 1976; Poulsen
et al., 1977; Lee et al., 1978). Hitherto it
has been accepted that early detection of
advanced disease and the removal of in-
volved spleens in HD should be beneficial
to the course of the disease. However,
early splenectomy in a group of 21
patients with HD treated with MOPP did
not influence duration of survival or long-
term remission when compared to his-
torical matched non-splenectomized con-
trols (Panettiere et al., 1977). No con-
trolled studies are available to elucidate
this question in less advanced HD.
This study was undertaken to evaluate
the effect of early diagnostic splenectomy
on prognosis in HD patients with un-
certain prognosis, but without signs of
splenic involvement.
MATERIALS AND METHODS
Patients. All previouslyuntreated patients
of 15-65 years of age admitted to Radium-
hemmet from January 1973 to April 1979
wiere considered for the study. The diagnosis
was established by lymphnode biopsy in all
patients except 2 who had the diagnosis
verified by aspiration biopsy (Bjorkholm et
al., 1977a). The Rye nomenclature was used
for lhistological classification (Lukes et al.,
1966): lymphocytic predominance (LP), nodu-
lar sclerosis (NS), mixed cellularity (MC) and
lymphocytic depletion (LD). All biopsy
specimens were reviewed by the same
pathologist (GS).
The clinical staging wNas based on a com-
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plete history, physical examination, liver-
function tests, marrow biopsy, chest and plain
abdominal X-rays, lymphangiography, and
liver and spleen scans. The Ann Arbor
nomenclature for clinical staging was used
(Carbone et al., 1971).
Immunological tests. Alluntreatedpatients
were tested. Lymphocytes were purified from
defibrinated blood by gelatin sedimentation
and treatment with carbonyl iron to remove
phagocytic cells. A total lymphocyte count
was made, and the lymphocyte DNA syn-
thesis was determined as the incorporation of
14C-thymidine after 3 days' culture ws%ith
Mitogens (pokeweed mitogen, concanavalin
A). The spontaneous DNA synthesis during
the first 24 h of culture was also determined
(Holm et al., 1976). The results wN-ere expressed
as the quotient:
Experimental log ct/min
Mean log ct/rnin of healthy controls
(2()-35 years old) (Bj6rkholm et al., 1977b).
Study protocol and treat"neit. The patients
were divided into 3 grloups according to prog-
nosis: Favourable, Stage IA and llA, LP and
NS wvith right-sided presentation; Unfavour-
able, Stage IV, all histological groups and
patients with enlarged spleens. Randomiza-
tion for splenectomy was not considered to
be justified in these 2 groups ofpatients. Only
patients without clinical evidence of splenic
involvement, in whom the prognosis was
regarded as uncertain, wvere included in the
study: Stage IA, IIA, LP and NS (left-sided
presentation), IA, IIA, MC and LD, Stage
IB, IIB and Il1, all histological groups.
These patients received total nodal irradlia-
tion, excluding the splenic and hepatic areas,
given wvith a 6MeV linear accelerator (Varian)
w7ith a mid-plane dose of 40-50 Gy. After the
initial treatment, consisting of mantle field or
inverted Y-field irradiation, depending on the
first presentation of disease, the patients
were stratified into 8 groups according to sex.
age (<35 and 35->) and histology (LP, NS and
MC, LD), and w,vere randomized for splenec-
tomy orno splenectomy. AfterlaparotomY the
2nd course of irradiation wAas started 8-10
weeks after the end of the initial treatment.
The interval between the 2 courses of irradia-
tion in the non-splenectomy group was 4-6
weeks. Patientsw%vhorelapsedwvvere treatedwith
quadruple-drug combination chemotherapy
(Bjorkholm et al., 1977a).
Sutrgical procedure. Laparotomy was per-
20
formed through a left paramedian incision
from the left costal margin to about 5 cm
below the umbilical level. The incision
allowNed thorough inspection and palpation of
the entire abdomen in order to map patho-
logical lymph nodes. Biopsy samples were
taken from the areas with lymphographic
suspicion of involvement. In cases with nega-
tive lymphangiograms, but palpable iliac,
para-aortic, coeliac, splenic or mesenteric
nodes, biopsy samples were taken, and the
sites were marked with metal clips. To avoid
complications, large blind dissections were
not performed. Before splenectomy the
splenic artery was ligated above the pancreas
through the lesser sac. Wedge liver biopsy
specimens were taken from any suspected
area or from the most accessible lobe.
In fertile women, the ovaries were moved
and fixed to the back ofthe neck ofthe uterus
and their lateral corners were marked w%ith
metal clips. Oophoropexy was also performed
in all fertile women, except in 2 controls.
The spleens were cut in 5mm transverse
sections and thoroughly inspected. Biopsy
specimens from suspected areas were ex-
amined inieroseopically.
RESULTS
The clinical material
At the end of the study, in April 1979,
67 patients had been entered; 31 were
randomized for splenectomy and 36 for no
splenectomy. The 2 groups were com-
parable with regard to sex, age, observa-
tion time, lymphangiographic findings,
clinical stage and histology (Tables I, II
and III). As revealed in prospective
studies, the immunological capacity evalu-
ated by lymphocyte-function tests (see
MATERIALS AND METHODS) is a strong prog-
nostic predictor in HD (Bjorkholm et al.,
1977a). The 2 groups were also com-
parable with regard to their immune
status (Table I).
The spleenwasremovedfrom 29 patients
in the splenectomy group (Table II). Two
patients in this group were not splen-
ectomized; Case 19 refused surgery and
inverted Y-field irradiation, but is still in
complete remission; Case 31 died from
gastric haemorrhage and generalized HD
before splenectomy.
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TABLE I.-Characterization of the patient
population
Total population
Sex: F
A
Age (years): median
range
Obs. time from diagnosis
(months): median
range
Clinical stage: I
II
III
Symptoms: A
B
Histology: LP
NS
MC
LD
Unclassifiecl
Immunological tests
Total lymphocytes
(log no./mm3)
DNA synthesis (mean log
quotient)
Spontaneous
Pokeweed mitogen (I utg/ml)
Concanavalin A (20 fig/ml)
Splen-
ecto-
mized
31
7
24
32
15-64
40
4-75
10
12
9
18
13
5
12
11
1
2
Non-
splen-
ecto-
mized
36
12
24
32
15-65
41
3-75
3
19
14
27
9
3
20
12
1
0
found in para-aortic nodes during surgery.
On the other hand, 1/17 cases with nega-
tive lymphangiograms had HD in the
biopsied abdominal lymph nodes. No
patient with equivocal lymphangiograms
had involvement ofthe biopsied abdominal
nodes. All 4 patients with their first RD
presentation in the inguinal lymph nodes
had positive lymphangiograms. They re-
ceived inverted Y-field irradiation before
laparotomy. No lymphnode tumour was
found during surgery. One of them had
tumour involvement in the spleen.
After splenectomy the clinical stage was
altered in 10 patients, 8 of them to a more
advanced stage (Table II). Two patients
with liver HD received quadruple-drug
chemotherapy after surgery, as did
patients in relapse.
Surgical complications
3-09 3-13 Early and late surgical complications
were found in 4 patients (Table II).
1-11 1-10
0-95 0-91
0-95 0-94
In the non-splenectomy group (Table
III) Case 51 was splenectomized on sus-
picion of progressive disease with rapidly
increasing spleen size. His spleen was
affected but was within the normal weight
range. He refused inverted Y-field treat-
ment, but is in complete remission 39
months after diagnosis. Case 52 was
nephrectomized because of a hyper-
nephroma. After 39 months he has no sign
of relapse from HD or hypernephroma.
Laparotomyfindings
In the splenectomy group spleens from
10 patients were involved (Table II). So
also was Case 31, who died before opera-
tion but was found to have splenic HD at
necropsy. In 2 patients, tumour was pre-
sent in spleen and liver. Seven patients
with positive lymphangiograms were
treated with mantle-field irradiation be-
fore laparotomy. In 4 of them tumour was
Infections
Four severe infections were recorded, 3
in the splenectomy group and 1 in the
non-splenectomy group (Tables II, III and
IV). Case 21 developed generalized herpes
zoster and pneumococcal septicaemia dur-
ing chemotherapy, 6 months after splen-
ectomy. Case 6 suffered a severe but non-
fatal pneumococcal septicaemia 34 months
after diagnosis. She was in complete re-
mission after chemotherapy for a pul-
monary recurrence. Case 30 died from
generalized varicella during radiotherapy.
In the non-splenectomy group Case 65
died of viral pneumonia. At necropsy no
signs of HD were found.
Prognosis
The patients were evaluated at a follow-
up in April 1979, 4-75 months after diag-
nosis. Relapse rates and patterns were
similar in both groups (Tables II and III).
However, the median time from diagnosis
to relapse for the splenectomy group was
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TABLE II.-Clinical characteristics, laparotomy findings and course of disease in
splenectomized patients
Laparotomy
findings
Case Age Lympho- Clinical = Post-op. Clinical
No. Sex (years) Histology graphy stage S H N stage course
Clinical
Period condi-
of tion
observa- at
tion follow-
(months) up
1 M 28 NS(MC)
2 M 20 MC
3 M 37 NS (MC)
4 M 48 MC
5 M 30 LP
6 F 28 Unclass
7 M 43 NS
8
9
10
11
12
13
14
15
16
17
F
M
M
M
M
F
F
M
M
M
25 Unclass
28 LP
59 LP
41 MC
29 LP
19 NS (LD)
32 NS
39 NS (MC)
28 NS (LP)
28 MC
+ IIA - - * IIA
- TIB + - + IIISNB
- II A - - - IIA Ileus twice
+ IIIA - - + IIINA
+ III A - - - IIA
- IIB - - - IIB Pulmonary
relapse 24
months,
sepsis 34
months
- IB + - - IIISB Axillary
relapse 20
months
+
+
+
+
IA - - *IA
IA - - IA
IB - - IB
II B + - - IIsB
IIA - - -tIIA
III B - - - II B Left cervical
relapse 31
months
IIA - - - IIA
IIIB - - -* IIB
IIA - - -tIIA
III A + - + IIISNA Ileus, hilar
relapse 30
months
18 M 64 MC - IA + - - IIISA
19 M 51 MC - IA refused
operation
20 F 39 MC - II A + - - IIIsA
21 M 54 MC - IB + + - IVSHB Wound de-
hiscence 2
wks, sepsis
12 months
22 M 15 NS(MC) + III B - - - II B Hilarrelapse
12 months
23 F 22 NS - II B - - - II B
24 M 40 LP - I A + - - IIISA Cicatric hernia
25 F 34 MC - I A - - - I A
26 M 23 MC + III B - - + IIINB Cervical
relapse
12 months
27 M 28 NS(MC) + IIIA + + + IVSHNA Progress
28 M 62 NS(MC) + II A - - - II A Abdominal
relapse
18 months
29 M 44 NS - II B - - - II B Costalrelapse
7 months
30 M 19 MC - I A + - - IIISA Generalized
varicella
7 months
31 M 60 LD + III B died before
operation
75
70
67
63
60
58
CR
CR
CR
CR
CR
CR
57 CR
56
53
52
48
47
47
47
40
40
39
39
37
28
24
15
14
14
12
42
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
PR
CR
CR
CR
t
25 t
24 t
18
7
t
t
4 t
Lymphography: + positive; - negative; ± equivocal.
Laparotomy findings: + affected organ; - unaffected organ; * no palpable nodes, no biopsy; t no
palpable nodes, no biopsy, treated inverted Y-field irradiation before laparotomy; CR =complete remission;
PR =partial remission; t =died.
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TABLE III.-Clinical characteristics and course of disease in non-splenectomized
patients
Case
No. Sex Age Histology
32 M
33 F
34 M
35 M
36 M
37 M
38 M
39 F
40 M
41 F
42 M
43 M
44 M
45 M
46 F
47 F
48 M
49 F
50 M
51 M
52 M
53 M
54 M
55 M
56 M
57 M
58 F
59 M
60 F
61 M
62 F
63 F
24
15
63
32
23
32
26
24
53
15
27
45
44
47
23
21
53
33
29
37
37
22
21
19
62
50
17
65
43
32
33
54
LP
NS
NS
MC
MC
NS
NS
NS(LP)
NS(MC)
LP
MC
LD
MC
MC
NS(MC)
NS
MC
NS(MC)
NS(MC)
MC(LD)
MC
NS
NS
NS
NS
LP
NS
NS
NS(MC)
NS(LP)
NS
NS(MC)
64 F 50 MC
65 F
66 M
67 M
30
51
57
MC
NS
MC
Lyrnpho- Clinical
graphy stage
- IIA
+ III A
+ III A
+ III A
+ III A
+ III B
- IIA
- IIA
+ III A
- IIA
+ III A
+ IIB
+ 1IAt - IIA
_ IA
- IIB
+ IIA
+ IIA
+ IIAt - IA
+ III A
+ III B
+ III B
- IIA
- IIB:
+ II Al
+
TI A
I A:
III A
III A
JI B
Clinical course
Axillary relapse
40 months
Axillary relapse
48 months
Pulmonaryrelapse
24 months
Inguinal relapse
29 months*
IV B, MOPP
regimen
Cervical relapse
36 months
Liver+spleens
relapse 25 months
Growing spleen,
splenectomized
Hypernephroma,
operation
Cervical relapse
28 months
Hypersplenism
14 months
Splenectomized
20 months
- IT A Progress spleen
uninvolved at
necropsy
+ III A Histiocytic
lymphoma at
necropsy
+ III B Viral pneumonia
NED at necropsy
+ III B Progress, bleeding
ulcer
- II A Progress, brain
metastases
Period
of
observation
(months)
75
75
72
72
71
70
69
68
66
65
65
63
63
53
53
53
52
41
41
39
39
38
34
24
22
22
20
19
15
9
3
28
21
18
8
8
* Patient refused oophoropexia, only para-aortic field.
t Died.
t Inverted Y-field treatment before mantle field.
CR =complete remission.
Clinical
condition
at
follow-up
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
CR
t
t
t
t
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TABLE IV.-Clinical course
Total number ofpatients
Relapses
Time from diagnosis to relapse
(montlhs)
AMedlian
Range
Bacterial septicaemia
Lethal viral infection
Deaths, total
, ; r
Splen-
ecto-
mized
31
8
190(
7-31
-P
) a.+w++++%t+;-# w-a-a: ..:......8+.rt.s..............z....-.. :..t.j,-::tt....
FIG(. 1. Actuiarial survival according to
splenectomy (31) or non-splenectomy (36)
19-0 months compared to 285 months in
the non-splenectomy group (P < 0 05,
Wilcoxon's test).
In the splenectomy group 6 patients
have died (Table II) compared with 5
deaths in the non-splenectomy group
(Table III). The diagnosis in Case 64 was
reassessed at necropsy to histiocytic
lymphoma. One patient in each group died
from viral infections without evidence of
HD. The survival determined according
to Cutler & Ederer (1958) revealed no
difference between the groups (Fig. 1;
Bjorkholm et al., 1977a).
DISCUSSION
The present study comprises 67 patients,
31 of whom were randomized for diag-
nostic splenectomy. In a follow-up con-
cluded in April 1979, there was no differ-
ence between the groups with regard to
mortality andtime ofsurvival. Six patients
have died in the splenectomy group and
5 in the non-splenectomy group. Viral in-
fections were the cause of death in 1
patient in each group. The others died from
the disease, except Case 64 (see above).
There was no difference in relapse fre-
quency between the 2 groups, but re-
lapses seemed to occur earlier among the
splenectomized patients. Splenectomy as
a therapeutic adjunct seems little justified,
particularly considering the serious nature
of the bacterial septicaemia in 2 splen-
ectomized cases (Chilcote et al., 1976;
Weitzman & Aisenberg, 1977).
Splenic involvement was seen in 11/30
cases, which is comparable with the
10-40% reported in other series (Kaplan
et al., 1973; Lee et al., 1978; Cannon et al.,
1974). On the basis of this figure, it is
highly unlikely that the spleens were un-
involved in all control patients. It should
also be noted that the splenic area was not
included in the irradiation field. Thus,
splenic recurrences would have been ex-
pected in some patients in the control
group. However, splenic involvement was
only noted in 3/8 recurrences in the con-
trol group. In one patient with initial
clinical Stage III A and a positive lymph-
angiogram, a liver relapse was suspected.
As liver involvement is almost always
associated with splenic involvement this
may be a recurrence caused by persisting
HD in the spleen. Another patient showed
signs of hypersplenism 14 months after
diagnosis. He was successfully splen-
ectomized, and has no signs of active
disease. Finally the 3rd patient in the
control group who had splenic involve-
ment was splenectomized after his mantle-
field treatment on suspicion of splenic
involvement. The incidence of sympto-
matic splenic recurrences in the non-
splenectomized group (3/36) is significantly
* 1W
a I. a
E
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lower than that of splenic HD in the
splenectomized patients (11/30; P < 0-001,
Fisher's exact test).
The reason so few splenic relapses have
appeared is as yet unknown. One possi-
bility is that splenic HD may heal in the
absence of disease in other locations. This
might parallel the rare occurrence of
tumour metastases in the spleen (McLure
& Hwa Park, 1975). Alternatively, the
histopathological picture in HD spleens
may be a sign of a reactive rather than a
malignant process (Amiel & Droz, 1978).
As a 3rd alternative, splenic recurrences
in non-splenectomized patients may occur
late in the disease, thereby escaping de-
tection during the period of observation.
However, the recurrences in the splen-
ectomized group were considerably earlier
than those in the non-splenectomized
group (Tables II and III). This is not
likely to depend on the longer interval
between the mantle and abdominal irradi-
ation in the splenectomized patients, as
6/8 recurrences occurred in the first
irradiated area. Moreover, the routine
splenectomizing of HD patients before
irradiation might favour tumour growth.
It may be concluded that early diag-
nostic splenectomy in HD under the treat-
ment protocol used in this study does not
improve prognosis. Rather, it may lead to
surgical complications, increased risk of
severe infections and may be associated
with earlier relapse ofdisease.
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